C反應(yīng)蛋白（CRP）ELISA（RUO）試劑盒：用于人血清中C-反應(yīng)蛋白的酶免疫測(cè)定。

艾美捷LDN-C反應(yīng)蛋白（CRP）ELISA（RUO）試劑盒（DME-4600R）：

名稱：C反應(yīng)蛋白（CRP）ELISA

描述：

用于人血清中C反應(yīng)蛋白的定量酶免疫測(cè)定。

設(shè)計(jì)：ELISA

樣品體積：

20 ?l 稀釋血清（1:20）

總測(cè)定時(shí)間：60分鐘

標(biāo)準(zhǔn)范圍：0/100 – 10,000 ng/ml

靈敏度：10 ng/ml

儲(chǔ)存：2 – 8 °C

試劑盒：96次測(cè)定

CE認(rèn)證：是

局限性：

1. 試劑盒內(nèi)所有試劑均校準(zhǔn)用于人血清中C反應(yīng)蛋白的直接測(cè)定。該試劑盒未校準(zhǔn)用于唾液、血漿或其他人或動(dòng)物來(lái)源樣本中CRP的測(cè)定。

2. 不要使用明顯溶血、明顯脂血、黃疸或儲(chǔ)存不當(dāng)?shù)难濉?/p>

3. 任何含有疊氮化物或硫柳汞的樣本或?qū)φ昭迮c本試劑盒不兼容，因?yàn)樗鼈兛赡軐?dǎo)致假結(jié)果。

4. 僅標(biāo)準(zhǔn)品A可用于稀釋高濃度血清樣本。使用任何其他試劑可能導(dǎo)致假結(jié)果。

注：溶血是指紅細(xì)胞破裂釋放出血紅蛋白，脂血是指血清中脂肪含量過(guò)高，黃疸是指血清中膽紅素水平升高，導(dǎo)致血清呈現(xiàn)黃色。疊氮化物和硫柳汞是常見(jiàn)的防腐劑，但可能會(huì)干擾某些生化試驗(yàn)。

LDN-C反應(yīng)蛋白（CRP）ELISA（RUO）試劑盒文獻(xiàn)參考：

1. Wilkins J, et al., Rapid Automated High Sensitivity Enzyme Immunoassay of C-reactive Protein. ClinChem. 1998; 44(6 Pt 1): 1358-61.

2. Ledue TB,et al. Analytical Evaluation of Particle- enhanced Immunonephelometric Assay for C-reactiveProtein, Serum Amyloid A and Mannose-binding Protein in Human Serum. Ann. Clin. Biochem. 1998; 35(Pt6): 745-53.

3. Macy EM, et al. Variability in the Measurement of C-reactive Protein in healthy Subjects: Implications forReference Intervals and Epidemiological Aplications. Clin. Chem. 1997;43(1):52-8.

4. K?pyaho K, et al. Rapid Determination of C-reactive Protein by Enzyme Immunoassay Using TwoMonoclonal Antibodies. Scand. J. Clin. Lab. Invest. 1989; 49(4):389-93.

5. Eda S, et al. A New Method of Measuring C-reactive Protein, with a Low Limit of Detection, Suitable forRisk Assessment of Coronary Heart Disease. Scand. J. Clin. Lab. Invest. 1999; 230:32-5

6. Borque L, et al. Development and Validation of an Automated and Ultrasensitive ImmunoturbidimetricAssay for C-reactive Protein, Clin Chem. 2000; 46(11):1839-42.

7. Roberst WL, et al. Evaluation of Nine Automated High-Sensitivity C-reactive Protein Methods:Implications for Clinical and Epidemiological Applications. Part 2. Clin. Chem. 2001; 47(3):418-25.

8. Rifai N, Ridker PM. High-sensitivity C-reactive Protein: a Novel and Promising Marker of Coronary HeartDisease. Clin. Chem. 2001; 47:403-11

9. Libby P, Ridker PM. Novel Inflammatory Markers of Coronary Risk: Theory Versus Practice. Circulation.1999; 100:1147-50.

10. Ross R. Atherosclerosis – An Inflammatory Disease. N Engl. J. Med. 199; 340(2):115-26.

11. Libby P. Molecular Bases of the Acute Coronay Syndromes. Circulation. 1995; 91:2844-50

12. Ridker PM, et al. C-reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovasculardisease in Women. N. Engl J Med. 2000; 342:826-43.

13. Ridker PM, et. al. Plasma Concentration of C-reactive Protein and Risk of Developing Peripheral VascularDisease. Circulation. 1998; 97:425-8

LDN Labor Diagnostika Nord GmbH & Co. KG（簡(jiǎn)稱LDN）旨在開(kāi)發(fā)、制造和向臨床和研究實(shí)驗(yàn)室市場(chǎng)提供專業(yè)的體外診斷測(cè)試系統(tǒng)和創(chuàng)新技術(shù)。艾美捷科技是LDN Labor Diagnostika Nord的中國(guó)代理商，為科研工作者提供優(yōu)質(zhì)的產(chǎn)品與服務(wù)。